Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Sahra Ali"'
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263195 (2022)
BackgroundAcute leukaemias (AL) are aggressive but potentially curable blood cancers that can potentially affect women of childbearing age. When a pregnancy is complicated by a diagnosis of AL, clinicians face a complex dilemma: to balance risking th
Externí odkaz:
https://doaj.org/article/ad2b956c62104d7294a973eebb9509dc
Autor:
Jamie Saunders, Natalia Curto-Garcia, Priya Sriskandarajah, Jennifer O’Sullivan, Claire Woodley, Susan Asirvatham, Marion Campbell-Drew, Jonathan Mathias, Tim Ellis, Nona Baker, Deepti H. Radia, Sahra Ali, Shahram Kordasti, Patrick Harrington, Hugues de Lavallade, Donal P. McLornan, Claire N. Harrison
Publikováno v:
HemaSphere, Vol 5, Iss 7, p e609 (2021)
Externí odkaz:
https://doaj.org/article/35ea45023d78488a8677879e2168635a
Autor:
Alesia Khan, Claire Woodley, Deepti Radia, George N. Mikhaeel, Jessica Brady, Natalia Curto Garcia, Patrick Harrington, Jennifer O’Sullivan, Shahram Kordasti, Yvonne Francis, Susan Asirvatham, Sahra Ali, Priya Sriskandarajah, Jamie Saunders, Hugues de Lavallade, Donal P. McLornan, Claire N. Harrison
Publikováno v:
HemaSphere, Vol 5, Iss 7, p e611 (2021)
Externí odkaz:
https://doaj.org/article/9bf13ba33ca94e558c21db22cc1d45ba
Autor:
Jorge Camarero, Filip Josephson, Maja Sommerfelt Grønvold, Nikolaos Zafiropoulos, Sahra Ali, Paula van Hennik, Christian Syvertsen, Bjorn Oddvar Strøm, Mats Ökvist, Brigitte Keller-Stanislawski, Elias Pean, Silvy da Rocha Dias, Franscesco Pignatti
Publikováno v:
ESMO Open, Vol 5, Iss 6 (2020)
On the 15 November 2018, the Committee for Medicinal Products for Human Use adopted an extension to an existing indication for the use of nivolumab (Opdivo) in combination with ipilimumab (Yervoy) for the first-line treatment of adult patients with i
Externí odkaz:
https://doaj.org/article/6b829280fb9f45478adefcbc1a162bb8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jorine E. Hartman, Felix J.F. Herth, Pallav Shah, Christophe Pison, Arschang Valipour, Dirk-Jan Slebos, Christine Abele, Irene Firlinger, Kiran Kothakuzhakal, Marina Duller, Bernd Lamprecht, Roland Kropfmueller, Kornelia Holzmann, Sandra Rathmeier, Ralf Hubner, Leonore Erdmann, Bettina Temmesfeld-Wollbrück, Christoph Ruwwe Glösenkamp, Wolfgang Gesierich, Frank Reichenberger, Christa Niehaus, Felix Herth, Ralf Eberhardt, Daniela Gompelmann, Brigitte Rump, Kaid Darwiche, Stephan Eisenmann, Ulrike Kaiser, Birte Schwarz, Ulrike Sampel, Christian Schumann, Robert Kaiser, Kathryn Schumann-Stoiber, Dirk Skowasch, Sabine Ring, Amandine Briault, Francois Arbib, Marie Jondot, Thierry Perez, Clement Fournier, Regis Matran, Michele Catto, Nathalie Bautin, Virginie De Broucker, Marie Willemin, Anne Prevotat, Ludivine Wemeau, Alice Gicquello, Morgane Foulon, Hasna Camara, Gaetan Deslee, Herve Vallerand, Sandra Dury, Delphine Gras, Margaux Bonnaire-Verdier, Romain Kessler, Sandrine Hirschi, Michele Porzio, Tristan Degot, Mathieu Canuet, Armelle Schuller, Julien Stauder, Sahra Ali Azouaou, Armelle Marceau, Hervé Mal, Yolande Costa, Pallav L. Shah, Justin Garner, Karthi Srikanthan, Cielito Caneja, John Thornton, Nick Ten Hacken, Jorine Hartman, Karin Klooster, Sonja Augustijn, Peter Bonta, Jouke Annema, Marianne van de Pol, Annika Goorsenberg
Publikováno v:
Respiratory Medicine, 206:107059. W.B. Saunders Ltd
Respiratory Medicine, 206:107059. W B SAUNDERS CO LTD
AIRFLOW-2 Study Group 2023, ' Computed tomographic airway morphology after targeted lung denervation treatment in COPD ', Respiratory Medicine, vol. 206, 107059 . https://doi.org/10.1016/j.rmed.2022.107059
Respiratory medicine, 206:107059. W.B. Saunders Ltd
Respiratory Medicine, 206:107059. W B SAUNDERS CO LTD
AIRFLOW-2 Study Group 2023, ' Computed tomographic airway morphology after targeted lung denervation treatment in COPD ', Respiratory Medicine, vol. 206, 107059 . https://doi.org/10.1016/j.rmed.2022.107059
Respiratory medicine, 206:107059. W.B. Saunders Ltd
This post-hoc analysis of the AIRFLOW-2 trial investigated the changes in airway CT-parameters after targeted lung denervation (TLD) and whether these changes are associated with treatment response. In the treatment group (n = 32), an improvement in
Publikováno v:
Torjussen, Sahra Ali Abdullahi. Fremstillingen av kolonialisme i norske lærebøker. Master thesis, University of Oslo, 2018
Externí odkaz:
http://hdl.handle.net/10852/65797
https://www.duo.uio.no/bitstream/handle/10852/65797/1/Masteroppgave-Sahra-Torjussen-ferdig.pdf
https://www.duo.uio.no/bitstream/handle/10852/65797/1/Masteroppgave-Sahra-Torjussen-ferdig.pdf
Autor:
Rampotas, Alexandros *, Carter-Brzezinski, Luke *, Somervaille, Tim C.P, Forryan, James *, Psaila, Bethan, Mead, Adam J, Garg, Mamta *, Laing, Heather *, Wallis, Louise *, Butt, Nauman M *, McConville, Conal *, Sahra, Ali *, McGregor, Andrew *, Cowan, Hannah *, Innes, Andrew J. *, Ewing, Joanne *, Carter, Matthew *, Dyer, Peter *, Teh, Chun Huat *, Francis, Sebastian *, Wadelin, Frances *, Harrison, Claire, Godfrey, Anna L *, Kulakov, Elizabeth *, McLornan, Donal P. *, Lambert, Jonathan *
Publikováno v:
In Blood 15 November 2022 140 Supplement 1:9721-9723
Autor:
Nigel H. Russell, Robert K. Hills, Lars Kjeldsen, Richard E. Clark, Sahra Ali, Paul Cahalin, Ian F. Thomas, Alan K. Burnett
The prognosis for younger patients with relapsed acute myeloid leukaemia (AML) is generally dismal. Allogeneic stem cell transplantation is the preferred therapy for these patients. As part of the UK NCRI AML17 trial, daunorubicin/clofarabine (DClo)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f716c1ce573d298177610e141eff84
Autor:
Irene Papadouli, Filip Josephson, Sabine Straus, Geanne Thole, Paula van Hennik, Pieter J Glerum, Sahra Ali, Dominik Karres, Carla Herberts, Negar Babae, Ralf Herold, Francesco Pignatti
Publikováno v:
Oncologist
On March 28, 2019, the Committee for Medicinal Products for Human Use adopted a positive opinion recommending the marketing authorization for the medicinal product plerixafor. The marketing authorization holder for this medicinal product is Genzyme E